BioCryst Pharmaceuticals, Inc.
BCRX · Healthcare · $2.1B
$8.33+0.73%
Price
$9.84
$8.27
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$165M
6/'26 vs prev quarter
Company Health
Market Cap$2.1B
Operating Margin-43.4%
Cash on Hand$353M16.7% of market cap
Free Cash Flow$253M11.9% of market cap
Short Float 19.8% · biweekly · settled 26.05.15
Among 327 Biotechnology peers
LowMedianHigh
PSR2.9xmedian 11.4xROE+84.7%median -54.5%
